NASDAQ : ELAB
-$0.02 (-2.07%)
NASDAQ
Graydon Bensler
Biotechnology
Healthcare
ELAB
33
US
USD
0.63
1.45
1.43
1.27
0.00
$590.08K
3.22
0.03
-0.49
-18.83
-$378.74
-$7.71M
-873.11%
-876.97%
-116.96%
-42.66%
0.00
0.00
0.00
2/5
0 Analysts
%
-2.10
3/9
$5.09M
$26.03M
$13.43M
-$9.29M
-$2.22M
-1.74
0.25
1.45
-116.96%
-46.11%
-2715.92%
-200.26%
23 days
| Name | Title |
|---|---|
| Graydon Bensler | Chief Executive Officer, Chief Financial Officer, Secretary & Director |
No votes yet today — be the first to share your view!
About PMGC Holdings Inc. (NASDAQ:ELAB) Stock
PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., the organization adopted its current name, PMGC Holdings Inc., in December 2024. Established in 2020, PMGC Holdings Inc. maintains its headquarters in Newport Beach, California. ...
2026-07-29 15:54:00
Company Reports 8,095,835 Shares of Common Stock Issued and Outstanding as of July 29, 2026, and Moves to Correct Third-Party Market Data That Understates Its Current Share Count and Market Capitalization Company Reports 8,095,835 Shares of Common Stock Issued and Outstanding as of July 29, 2026, and Moves to Correct Third-Party Market Data That Understates Its Current Share Count and Market Capitalization
2026-07-28 07:30:00
NEWPORT BEACH, Calif. , July 28, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (NASDAQ: ELAB) (the "Company," "PMGC," "we," or "our"), a diversified holding company executing a precision manufacturing growth strategy across the aerospace and defense supply chain, today announced that its wholly owned subsidiary, A&B Aerospace, Inc.
2026-07-27 07:30:00
NorthStrive Defense Tech Engages Defense Software and Security Firm Deploy360 to Validate Patented GPS-Denied Drone Navigation Technology Under Option to L
2026-07-13 07:30:00
Definitive license agreement formalizes exclusive, worldwide, sublicensable rights to patented multi-domain drone payload technology for aerospace and defense applications Agreement follows the binding term sheet and sponsored research agreement announced earlier this year License covers U. S. Patent No. 12,291,334 and related know-how, with a multi-year development plan targeting prototype completion, non-dilutive funding applications, and first commercial sale NEWPORT BEACH, Calif.
2026-07-13 07:30:00
NorthStrive Defense Tech Executes Definitive Exclusive License Agreement with Florida State University Research Foundation for Multi-Domain Drone Payload T
2026-07-10 07:30:00
Independent flow cytometry (FACS) study will quantify latent myostatin antigen expression on NorthStrive-manufactured Lactobacillus casei and establish comparability against EL-22 material previously manufactured by MOA Life Plus Co. Ltd. Work is intended to strengthen EL-22 product identity and manufacturing consistency as NorthStrive advances a differentiated engineered probiotic designed to help preserve muscle during weight loss, including with GLP-1 receptor agonists NEWPORT BEACH, Calif.
PMGC Holdings Inc. Announces Merger of AGA Precision Systems into A&B Aerospace
2026-07-06 07:30:00
Strategic consolidation of two precision manufacturing portfolio companies expected to streamline operations, shared resources, and strengthen the companies' aerospace manufacturing platform NEWPORT BEACH, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (Nasdaq: ELAB) (“PMGC” or the “Company”) today announced that it has merged AGA Precision Systems LLC (“AGA”) into A&B Aerospace, Inc. (“A&B Aerospace”), with A&B Aerospace expected to be the surviving operating entity.
Frequently Asked Questions
What is the current PMGC Holdings Inc. (ELAB) stock price?
PMGC Holdings Inc.(NASDAQ:ELAB) stock price is $0.901 in the last trading session. During the trading session, ELAB stock reached the peak price of $309.89474 while $0.84 was the lowest point it dropped to. The percentage change in ELAB stock occurred in the recent session was --2.07% while the dollar amount for the price change in ELAB stock was -$0.02.
ELAB's industry and sector of operation?
The NASDAQ listed ELAB is part of Biotechnology industry that operates in the broader Healthcare sector.
Who are the executives of ELAB?
Graydon Bensler
| Chief Executive Officer, Chief Financial Officer, Secretary & Director
|
|
|
|
How many employees does ELAB have?
Number of ELAB employees currently stands at 33. ELAB operates from 120 Newport Center Drive, Newport Beach, CA 92660, US.
Link for ELAB official website?
Official Website of ELAB is: https://pmgcholdings.com
How do I contact ELAB?
ELAB could be contacted at phone #866 445 4886 and can also be accessed through its website. ELAB operates from 120 Newport Center Drive, Newport Beach, CA 92660, US.
How many shares of ELAB are traded daily?
The average number of ELAB shares traded daily for last 3 months was 2.99M.
What is the market cap of ELAB currently?
The market value of ELAB currently stands at $4.09M with its latest stock price at $0.901